Onward Medical NV ONWD

BRU: ONWD | ISIN: NL0015000HT4   09:04
5,240 EUR (+1,75%)
(+1,75%)   09:04

18 september 2025 · Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy · Persbericht

8 september 2025 · ONWARD Medical Receives CE Mark for ARC-EX, Enabling Commercial Launch of Breakthrough Spinal Cord Stimulation System in Europe · Persbericht

2 september 2025 · ONWARD Medical Demonstrates Commercial Traction and Advances Pipeline in the First Half of 2025 · Persbericht

18 augustus 2025 · ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System · Persbericht

6 augustus 2025 · ONWARD Medical annonce la nomination de Lucas Buchanan à son conseil d’administration · Persbericht

6 augustus 2025 · ONWARD Medical Announces the Appointment of Lucas Buchanan to its Board of Directors · Persbericht

7 juli 2025 · ONWARD Medical Adds Entrepreneur and Neurotechnology Thought Leader Tim Denison, PhD to its Board of Directors · Persbericht

1 juli 2025 · ONWARD Medical Files 510(k) with US FDA for ARC-EX System Home Use and Submits CE Mark Application · Persbericht

17 juni 2025 · ONWARD Medical Builds Commercial Momentum for the ARC-EX System and Reinforces its Brain-Computer Interface Leadership in Q1 2025 · Persbericht

11 juni 2025 · ONWARD Medical Announces Results of its Annual General Meeting of Shareholders · Persbericht

11 juni 2025 · ONWARD Medical Schedules Webcast to Provide Q1 2025 Business Update and Year-To-Date Highlights · Persbericht

21 mei 2025 · ONWARD Medical Advances Brain-Computer Interface Leadership with Fourth and Fifth Successful BCI Implants · Persbericht

30 april 2025 · ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders and Proposed Resolutions · Persbericht

28 april 2025 · ONWARD Medical Announces Release of 2024 Annual Report · Persbericht

24 april 2025 · ONWARD Medical Establishes US ADR Program and Begins Trading on OTCQX Best Market · Persbericht

1 april 2025 · ONWARD Medical Reports Full Year 2024 Financial and Operating Results and Shares 2025 Year-to-Date Highlights · Persbericht

1 april 2025 · ONWARD Medical publie ses résultats financiers et opérationnels pour l’exercice 2024 et partage ses faits marquants du début de l’année 2025 · Persbericht

26 maart 2025 · ONWARD Medical Announces First-in-Human Use of ARC-IM Lumbar Lead Designed to Restore Standing, Stepping, and Lower Limb Mobility · Persbericht

19 maart 2025 · ONWARD Medical Schedules Reporting of Full Year 2024 Financial Results and Business Update Webcast · Persbericht

4 maart 2025 · ONWARD Medical to Advance Parkinson’s Disease Pipeline with Support from The Michael J. Fox Foundation and US Department of Defense · Persbericht

Mijn selecties